Hosted on MSN3d
Will Spotify’s Bundling Craze Delay Its Remix and Mashup Features? NMPA Digs in Amid Latest ‘Super-Premium’ TeaserWill an intensifying showdown between music publishers and Spotify derail the forthcoming Super-Premium plan – or at least ...
Pharmaceuticals announced the NMPA, National Medical Products Administration, approval of Cumberland’s Vibativ injection in ...
Akeso Inc. has received IND approval by China’s National Medical Products Administration (NMPA) for AK-139, an IL-4Rα/ST2 ...
CSPC Pharmaceutical Group Ltd. has gained clinical trial clearance from China’s National Medical Products Administration (NMPA) for SYS-6017, an mRNA vaccine to prevent herpes zoster infections.
From Warner’s Spotify and Amazon deals to Sir Lucian Grainge’s 2025 memo… it’s MBW’s Weekly Round-Up
Welcome to Music Business Worldwide’s weekly round-up – where we make sure you caught the five biggest stories to hit our ...
This is not the first time the NMPA has gone after Spotify. The group sued the company in June of 2024 for its music-audiobook bundling deal, claiming it cut royalties for songwriters. Spotify ...
“This regulatory clearance from the NMPA marks an important milestone in advancing our efforts to address significant unmet needs in immunological diseases,” said Dr. Jingsong Wang, Founder, Chairman, ...
Music publishers in the US have started issuing takedown notices in relation to unlicensed music in Spotify podcasts. Spotify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback